Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

Recent studies reveal that while manganese is crucial for health, its excess can lead to neurological disorders similar to ...

Gut microbiota and phytochemicals synergize to produce bioactive metabolites that combat aging, reduce inflammation, and ...

Researchers have made a major breakthrough in our understanding of Huntington's disease. This genetic disorder has long been ...

Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen approximately twenty years before a clinical motor diagnosis in people with Huntington's ...

Approximately 23 years before a clinical diagnosis, CSF analysis showed very early signs of neurodegeneration with elevated ...

A new study has identified three psychological profiles that influence brain health, cognitive decline, and dementia risk in ...

Studies of living participants and postmortem brains confirm that gene expansion is a promising target for HD prevention ...

Butovsky believes xenon has potential as an AD treatment. A Phase 1 clinical trial of xenon at BWH is recruiting healthy elderly volunteers to test safety and effects on immune cells. “I hope this ...

Having 35 copies of the CAG triplet in the gene that causes Huntington’s disease is not a problem. Inheriting 40 could be a ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...